-       Report 
   - September 2025
    -  250 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                      Strabismus is a condition in which the eyes do not align properly, resulting in a misalignment of the visual axes. Optical Disorders Drugs are used to treat strabismus, and the Strabismus Drug market is a subset of the larger Optical Disorders Drug market. Strabismus Drugs are used to treat the underlying cause of the misalignment, such as muscle imbalance or nerve damage. These drugs can be administered orally, topically, or through injections. Commonly used Strabismus Drugs include botulinum    toxin, cycloplegic agents, and anticholinesterase agents.
The Strabismus Drug market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Allergan, Novartis, Pfizer, Merck, and Santen Pharmaceuticals. Show Less   Read more